5-fluorouridine
- Generic Name
- 5-fluorouridine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11FN2O6
- CAS Number
- 316-46-1
- Unique Ingredient Identifier
- 4K0M952561
- Background
5-fluorouridine is also known as FUrd, 5-Fluorouracil 1-beta-D-ribofuranoside, 5-Fur, or 5-Fluoro-uridine. 5-fluorouridine is a solid. This compound belongs to the pyrimidine nucleosides and analogues. These are compounds comprising a pyrimidine base attached to a sugar. 5-fluorouridine is known to target uridine phosphorylase. FUrd is often used in chemical and biochemical comparison studies with fluorouracil and thymine analogs.
- Associated Conditions
- -
- Associated Therapies
- -
A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2021-12-08
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT05148195
- Locations
- 🇨🇳
Sun Yat-sen University affiliated with the Sixth Hospital, Guangzhou, China
🇨🇳Shaw Hospital Affiliated to Medical College of Zhejiang Universit, Hangzhou, China
🇨🇳Beijing Cancer Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.